Liver osteopontin is required to prevent the progression of age‐related nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Liver osteopontin is required to prevent the progression of age‐related nonalcoholic fatty liver disease

Published:2020-07-07 Issue:8 Volume:19 Page:
ISSN:1474-9718
Container-title:Aging Cell
language:en
Short-container-title:Aging Cell

Author:

Gómez‐Santos Beatriz¹^ORCID,Saenz de Urturi Diego¹,Nuñez‐García Maitane¹,Gonzalez‐Romero Francisco¹,Buque Xabier¹²,Aurrekoetxea Igor¹²,Gutiérrez de Juan Virginia³,Gonzalez‐Rellan Maria J.⁴⁵,García‐Monzón Carmelo⁶⁷,González‐Rodríguez Águeda⁶⁷,Mosteiro Lorena²,Errazti Gaizka²,Mifsut Patricia²,Gaztambide Sonia²,Castaño Luis²,Martin Cesar⁸,Nogueiras Rubén⁴⁵,Martinez‐Chantar María L.³⁷,Syn Wing‐Kin¹⁹¹⁰,Aspichueta Patricia¹²^ORCID

Affiliation:

1. Department of Physiology Faculty of Medicine and Nursing University of Basque Country UPV/EHU Leioa Spain

2. Biocruces Bizkaia Health Research Institute Cruces University Hospital Barakaldo Spain

3. Liver Disease Lab, Center for Cooperative Research in Bioscience (CIC bioGUNE), Basque Research and Technology Alliance (BRTA) e Derio Bizkaia Spain

4. Department of Physiology CIMUS University of Santiago de Compostela‐Instituto de Investigación Sanitaria Santiago de Compostela Spain

5. CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn) Madrid Spain

6. Liver Research Unit Santa Cristina University Hospital Instituto de Investigación Sanitaria Princesa Madrid Spain

7. Centro de investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute Madrid Spain

8. Department of Biochemistry and Molecular Biology Biofisika Institute (UPV/EHU, CSIC) UPV/EHU Spain

9. Section of Gastroenterology Ralph H Johnson VAMC Charleston SC USA

10. Division of Gastroenterology and Hepatology Medical University of South Carolina Charleston SC USA

Funder

Ministerio de Economía y Competitividad

Eusko Jaurlaritza

Publisher

Wiley

Subject

Cell Biology,Ageing

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/acel.13183

Reference53 articles.

1. Senescence in chronic liver disease: Is the future in aging?

2. Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity

3. Endoplasmic Reticulum Stress and Lipid Metabolism: Mechanisms and Therapeutic Potential

4. Elevated Expression of Osteopontin May Be Related to Adipose Tissue Macrophage Accumulation and Liver Steatosis in Morbid Obesity

5. Nonalcoholic fatty liver disease and aging: Epidemiology to management

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathway;Cell Reports Medicine;2024-07

2. Involvement of Matricellular Proteins in Cellular Senescence: Potential Therapeutic Targets for Age-Related Diseases;International Journal of Molecular Sciences;2024-06-15

3. Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth;Metabolism;2024-05

4. Osteopontin Rejuvenates Senescent Adipose-Derived Stem Cells and Restores their Bone Tissue Regenerative Function;Stem Cell Reviews and Reports;2024-03-12

5. Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe;Frontiers in Endocrinology;2024-03-08